Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
Author:
Affiliation:
1. Diabetes Research Institute Mills‐Peninsula Medical Center San Mateo California USA
2. Emergo by UL Chicago Illinois USA
3. Emergo by UL Concord Massachusetts USA
4. Novo Nordisk A/S Søborg Denmark
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13429
Reference18 articles.
1. Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience
2. Evolution of Diabetes Insulin Delivery Devices
3. Novo Nordisk.Ozempic®(semaglutide) prescribing information 2020. Available from:https://www.novo‐pi.com/ozempic.pdfAccessed June 16 2020.
4. Novo Nordisk.Ozempic®(semaglutide) summary of product characteristics 2018. Available from:https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/004174/WC500244163.pdfAccessed June 16 2020.
5. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Principles of Interoperability of Diabetes Devices;Journal of Diabetes Science and Technology;2024-08-05
2. Quantifying Patient Capabilities and Setting the Stage for Future Development: Insights from a Sensor-Augmented Simulated Use Study with Pen Injectors;Medical Devices: Evidence and Research;2024-07
3. Connected health services: Health professionals’ role as seen by parents of a child with inflammatory bowel disease;DIGITAL HEALTH;2024-01
4. Driver Head Pose Detection From Naturalistic Driving Data;IEEE Transactions on Intelligent Transportation Systems;2023-09
5. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions;Expert Opinion on Drug Delivery;2023-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3